Bénéfices
| Q1 2024 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.510 | ||
| Révision: | $92.25M | $67.01M | — |
| Q4 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.600 | 0.700 | -0.9000 |
| Révision: | $94.75M | $78.05M | $5.08M |
| Q3 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.720 | 1.580 | -0.1400 |
| Révision: | $96.14M | $88.07M | $12.15M |
| Q2 2023 | Évaluation | Réelle | Surprise |
|---|---|---|---|
| BPA: | 1.780 | 1.370 | -0.4100 |
| Révision: | $90.81M | $67.25M | $9.10M |
